Literature DB >> 22286195

Pleiotropic effects of statins: the role of eicosanoid production.

Yochai Birnbaum1, Yumei Ye.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22286195     DOI: 10.1007/s11883-012-0232-5

Source DB:  PubMed          Journal:  Curr Atheroscler Rep        ISSN: 1523-3804            Impact factor:   5.113


× No keyword cloud information.
  27 in total

1.  Inducible nitric oxide synthase binds, S-nitrosylates, and activates cyclooxygenase-2.

Authors:  Sangwon F Kim; Daniel A Huri; Solomon H Snyder
Journal:  Science       Date:  2005-12-23       Impact factor: 47.728

Review 2.  Regulation of the mevalonate pathway.

Authors:  J L Goldstein; M S Brown
Journal:  Nature       Date:  1990-02-01       Impact factor: 49.962

Review 3.  Rho GTPases and signaling networks.

Authors:  L Van Aelst; C D'Souza-Schorey
Journal:  Genes Dev       Date:  1997-09-15       Impact factor: 11.361

4.  Atorvastatin reduces plaque vulnerability in an atherosclerotic rabbit model by altering the 5-lipoxygenase pathway.

Authors:  Guangyi Zhou; Song Ge; Dezhi Liu; Gelin Xu; Renliang Zhang; Qin Yin; Wusheng Zhu; Jieli Chen; Xinfeng Liu
Journal:  Cardiology       Date:  2010-03-16       Impact factor: 1.869

5.  Prostaglandins mediate the cardioprotective effects of atorvastatin against ischemia-reperfusion injury.

Authors:  Yochai Birnbaum; Yumei Ye; Salvatore Rosanio; Shahin Tavackoli; Zhao-Yong Hu; Ernst R Schwarz; Barry F Uretsky
Journal:  Cardiovasc Res       Date:  2005-02-01       Impact factor: 10.787

6.  Effect of a single 20-mg tablet of Atorvastatin on brachial artery blood flow in normolipidemic male smokers versus nonsmokers.

Authors:  Kiyoshi Iida; Sorel Goland; Takashi Akima; Huai Luo; Yochai Birnbaum; Robert J Siegel
Journal:  Am J Cardiol       Date:  2007-06-28       Impact factor: 2.778

7.  Variation in eicosanoid genes, non-fatal myocardial infarction and ischemic stroke.

Authors:  Rozenn N Lemaitre; Kenneth Rice; Kristin Marciante; Joshua C Bis; Thomas S Lumley; Kerri L Wiggins; Nicholas L Smith; Susan R Heckbert; Bruce M Psaty
Journal:  Atherosclerosis       Date:  2008-11-01       Impact factor: 5.162

8.  Effect of intensive atorvastatin therapy on prostaglandin E2 levels and metalloproteinase-9 activity in the plasma of patients with non-ST-elevation acute coronary syndrome.

Authors:  Almudena Gómez-Hernández; Eva Sánchez-Galán; Mónica Ortego; José Luis Martín-Ventura; Luis Miguel Blanco-Colio; Nieves Tarín-Vicente; José Julio Jiménez-Nacher; Lorenzo López-Bescos; Jesús Egido; José Tuñón
Journal:  Am J Cardiol       Date:  2008-04-22       Impact factor: 2.778

9.  Phosphorylation of 5-lipoxygenase at ser523 by protein kinase A determines whether pioglitazone and atorvastatin induce proinflammatory leukotriene B4 or anti-inflammatory 15-epi-lipoxin a4 production.

Authors:  Yumei Ye; Yu Lin; Jose R Perez-Polo; Barry F Uretsky; Zaiming Ye; Brian C Tieu; Yochai Birnbaum
Journal:  J Immunol       Date:  2008-09-01       Impact factor: 5.422

10.  A systems biology strategy reveals biological pathways and plasma biomarker candidates for potentially toxic statin-induced changes in muscle.

Authors:  Reijo Laaksonen; Mikko Katajamaa; Hannu Päivä; Marko Sysi-Aho; Lilli Saarinen; Päivi Junni; Dieter Lütjohann; Joél Smet; Rudy Van Coster; Tuulikki Seppänen-Laakso; Terho Lehtimäki; Juhani Soini; Matej Oresic
Journal:  PLoS One       Date:  2006-12-20       Impact factor: 3.240

View more
  9 in total

1.  High-dose simvastatin exhibits enhanced lipid-lowering effects relative to simvastatin/ezetimibe combination therapy.

Authors:  Stuart G Snowden; Dmitry Grapov; Magnus Settergren; Fabio Luiz D'Alexandri; Jesper Z Haeggström; Oliver Fiehn; Tuulia Hyötyläinen; Theresa L Pedersen; John W Newman; Matej Orešič; John Pernow; Craig E Wheelock
Journal:  Circ Cardiovasc Genet       Date:  2014-12

2.  Simvastatin and a Plant Galactolipid Protect Animals from Septic Shock by Regulating Oxylipin Mediator Dynamics through the MAPK-cPLA2 Signaling Pathway.

Authors:  Maria Karmella Apaya; Chih-Yu Lin; Ching-Yi Chiou; Chung-Chih Yang; Chen-Yun Ting; Lie-Fen Shyur
Journal:  Mol Med       Date:  2016-03-31       Impact factor: 6.354

3.  Identification and signature profiles for pro-resolving and inflammatory lipid mediators in human tissue.

Authors:  Romain A Colas; Masakazu Shinohara; Jesmond Dalli; Nan Chiang; Charles N Serhan
Journal:  Am J Physiol Cell Physiol       Date:  2014-04-02       Impact factor: 4.249

4.  Cardioprotective potential of simvastatin in the hyperhomocysteinemic rat heart.

Authors:  Ankur Rohilla; M U Khan; Razia Khanam
Journal:  J Adv Pharm Technol Res       Date:  2012-07

5.  Simvastatin Increases Fibulin-2 Expression in Human Coronary Artery Smooth Muscle Cells via RhoA/Rho-Kinase Signaling Pathway Inhibition.

Authors:  Noemí Serra; Roser Rosales; Lluís Masana; Joan-Carles Vallvé
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

6.  Simvastatin and Benznidazole-Mediated Prevention of Trypanosoma cruzi-Induced Endothelial Activation: Role of 15-epi-lipoxin A4 in the Action of Simvastatin.

Authors:  Carolina Campos-Estrada; Ana Liempi; Fabiola González-Herrera; Michel Lapier; Ulrike Kemmerling; Barbara Pesce; Jorge Ferreira; Rodrigo López-Muñoz; Juan D Maya
Journal:  PLoS Negl Trop Dis       Date:  2015-05-15

7.  Atorvastatin treatment modulates the interaction between leptin and adiponectin, and the clinical parameters in patients with type II diabetes.

Authors:  Sayer I Al-Azzam; Asem M Alkhateeb; Karem H Alzoubi; Raya N Alzayadeen; Mera A Ababneh; Omar F Khabour
Journal:  Exp Ther Med       Date:  2013-10-15       Impact factor: 2.447

Review 8.  Enabling Precision Cardiology Through Multiscale Biology and Systems Medicine.

Authors:  Kipp W Johnson; Khader Shameer; Benjamin S Glicksberg; Ben Readhead; Partho P Sengupta; Johan L M Björkegren; Jason C Kovacic; Joel T Dudley
Journal:  JACC Basic Transl Sci       Date:  2017-06-26

9.  Relationship between inflammatory markers and new cardiovascular events in patients with acute myocardial infarction who underwent primary angioplasty.

Authors:  Eluisa La Franca; Marco Caruso; Angela Sansone; Rosanna Iacona; Laura Ajello; Dario Mancuso; Fabiana Castellano; Salvatore Novo; Pasquale Assennato
Journal:  Glob J Health Sci       Date:  2013-03-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.